Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product - PubMed (original) (raw)
Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product
U Santhanam et al. Proc Natl Acad Sci U S A. 1991.
Abstract
The aberrant overexpression of interleukin 6 (IL-6) is implicated as an autocrine mechanism in the enhanced proliferation of the neoplastic cell elements in various B- and T-cell malignancies and in some carcinomas and sarcomas; many of these neoplasms have been shown to be associated with a mutated p53 gene. The possibility that wild-type (wt) p53, a nuclear tumor-suppressor protein, but not its transforming mutants might serve to repress IL-6 gene expression was investigated in HeLa cells. We transiently cotransfected these cells with constitutive cytomegalovirus (CMV) enhancer/promoter expression plasmids overproducing wt or mutant human or murine p53 and with appropriate chloramphenicol acetyltransferase (CAT) reporter plasmids containing the promoter elements of human IL-6, c-fos, or beta-actin genes or of porcine major histocompatibility complex (MHC) class I gene in pN-38 to evaluate the effect of the various p53 species on these promoters. Murine and human wt p53 derived from pCMVNc9 and pC53-SN3, respectively, strongly repressed the IL-6 (promoter position -225 to +13), c-fos (-711 to +42), beta-actin (-3400 to +912), and MHC (-528 to -38) promoters in serum-induced HeLa cells; additionally, IL-6 promoter/CAT transcription unit constructs induced by IL-1, phorbol ester, or pseudorabies virus were also repressed by wt human and murine p53. The murine transforming mutant p53 (pCMVc5) was less active in repressing the IL-6, c-fos, beta-actin, and MHC promoter constructs. The human p53 mutant derived from pC53-SCX3 was also less active than the wt protein in repressing the IL-6, c-fos, beta-actin, and MHC promoters, except that serum-induced IL-6/CAT expression was equally repressed by both human wt and mutant p53. In similar transient transfection experiments in HeLa cells, overexpression of the wt human retinoblastoma susceptibility gene product, RB, was found to repress the serum-induced IL-6 (-225 to +13), c-fos (-711 to +42), and beta-actin (-3400 to +912) promoters but not the PRV-induced IL-6 (-110 to +13) or the serum-induced MHC (-528 to -38) promoters. These observations identify transcriptional repression as a property of p53 and suggest that p53 and RB may be involved as transcriptional repressors in modulating IL-6 gene expression during cellular differentiation and oncogenesis.
Similar articles
- Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
Pesch J, Brehm U, Staib C, Grummt F. Pesch J, et al. J Interferon Cytokine Res. 1996 Aug;16(8):595-600. doi: 10.1089/jir.1996.16.595. J Interferon Cytokine Res. 1996. PMID: 8877730 - A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation.
Ray A, Sassone-Corsi P, Sehgal PB. Ray A, et al. Mol Cell Biol. 1989 Dec;9(12):5537-47. doi: 10.1128/mcb.9.12.5537-5547.1989. Mol Cell Biol. 1989. PMID: 2511437 Free PMC article. - On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
Ray A, LaForge KS, Sehgal PB. Ray A, et al. Mol Cell Biol. 1990 Nov;10(11):5736-46. doi: 10.1128/mcb.10.11.5736-5746.1990. Mol Cell Biol. 1990. PMID: 2233715 Free PMC article. - Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
Deb S, Jackson CT, Subler MA, Martin DW. Deb S, et al. J Virol. 1992 Oct;66(10):6164-70. doi: 10.1128/JVI.66.10.6164-6170.1992. J Virol. 1992. PMID: 1356162 Free PMC article. - [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
Pospelova TV, Medvedev AV, Kisliakova TV, Svetlikova SB, Pospelov VA. Pospelova TV, et al. Mol Biol (Mosk). 1991 Jan-Feb;25(1):105-15. Mol Biol (Mosk). 1991. PMID: 1716733 Russian.
Cited by
- Mammalian p53 can function as a transcription factor in yeast.
Schärer E, Iggo R. Schärer E, et al. Nucleic Acids Res. 1992 Apr 11;20(7):1539-45. doi: 10.1093/nar/20.7.1539. Nucleic Acids Res. 1992. PMID: 1579447 Free PMC article. - Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.
Milne DM, Palmer RH, Meek DW. Milne DM, et al. Nucleic Acids Res. 1992 Nov 11;20(21):5565-70. doi: 10.1093/nar/20.21.5565. Nucleic Acids Res. 1992. PMID: 1454521 Free PMC article. - p53-mediated cell death: relationship to cell cycle control.
Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P, Oren M. Yonish-Rouach E, et al. Mol Cell Biol. 1993 Mar;13(3):1415-23. doi: 10.1128/mcb.13.3.1415-1423.1993. Mol Cell Biol. 1993. PMID: 8441387 Free PMC article. - Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.
Ueba T, Nosaka T, Takahashi JA, Shibata F, Florkiewicz RZ, Vogelstein B, Oda Y, Kikuchi H, Hatanaka M. Ueba T, et al. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9009-13. doi: 10.1073/pnas.91.19.9009. Proc Natl Acad Sci U S A. 1994. PMID: 8090761 Free PMC article. - Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J, Lin J, Levine AJ. Chen J, et al. Mol Med. 1995 Jan;1(2):142-52. Mol Med. 1995. PMID: 8529093 Free PMC article.
References
- Am J Pathol. 1989 Sep;135(3):427-33 - PubMed
- Mol Cell Biol. 1989 Dec;9(12):5537-47 - PubMed
- Mol Cell Biol. 1984 Oct;4(10):1961-9 - PubMed
- Mol Cell Biol. 1985 Oct;5(10):2851-5 - PubMed
- EMBO J. 1990 Jun;9(6):1897-906 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous